T1	Participants 156 174	gynecologic cancer
T2	Participants 459 495	Canadian Task Force classification I
T3	Participants 506 593	Gynecologic Oncology Unit of the Catholic University of the Sacred Heart in Rome, Italy
T4	Participants 604 748	Fifty patients with early cervical cancer (FIGO stages IA2, IB1, IIA <2 cm) or locally advanced cervical cancer (FIGO stages IB2, IIA >2cm, IIB)
